ON CASE The charmacie od Merck pharmaceutical firm schermo for 141 W More plans to quition of Scher Pouches through the fourth quarter of 200. Med says it then will name the heads of five mindstobal human health commer health care (4) manufacturing and Merck eshte The leaders of each divion will answer to Merck Clochard Clark. They formed structure will aid Merck in penetrating the vaccine and blogs markets, as well emerging markets About 40 percent of Schering Ploughs SEP-56 or leaders will be part of the newly combined company and a stata majority of Scheng Plough employees will remain with the combined company Acquiring Schering-Plough allows Merck to leapfrog to number two worldwide.just behind Pfizer. The new Merck will have about $42.4 billion in annual sales. Merck and Schering Plough are already partners on the blockbuster cholesterol drugs Vytorin and Zetia. The marriage will unite Merck's asthma and allergy treatment Singular and cervical Cancer vaccine Gardasil with Schering Plough's allergy Spray Nasonex and well known consumer products including the Coppertone sun care line and Dr. Scholl's foot care items. Buying Schering-Plough also boosts Merck's sagging pipeline of drugs in development, gives it a sizable biotech unit and creates a dominant player in vaccines as well as cholesterol, respiratory, and women's drugs. For the toolbar, press ALT+F10 (PC) or ALT+FN+F10 (Mac). BIUS Paragraph Arial 14px v !!!